A Study to Assess the Safety and Tolerability, Including Gastrointestinal Safety, Pharmacokinetics and Pharmacodynamics of ASP7657 in Caucasian Healthy Male and Female Subjects

Clinical trial NCT02108548 · TERMINATED

Trial details

NCT number: NCT02108548
Sponsor: Astellas Pharma Europe B.V.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Pharmacokinetics of ASP7657 Pharmacodynamics of ASP7657 Healthy Subjects

Start date: 2014-04-01
Primary completion: 2015-03-01
Enrollment: 89

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.